Fig. 3From: RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancerEvaluation the 10-RBPs signature in training cohort (A) and testing cohort (B). The transcript difference of 10 RBPs between high-risk group and low-risk group were presented in heatmap; Boxplot to show the difference of risk value between alive patients and dead patients; Stacked column chart was employed to present the proportion of alive and dead patients between high-risk group and low-risk group; Survival plot was conducted to exhibit the prognostic difference between high-risk group and low-risk group; Forest plot presented the multivariate Cox regression of 10-RBPs signature and clinical parameters; Prediction ability of 10-RBPs signature and other clinical factors were displayed in tAUC curves; Barplot to show the difference of AUC towards various indicatorsBack to article page